OCBV
EW icon

Ownership Capital B.V.’s Edwards Lifesciences EW Stock Holding History

Ownership Capital B.V.’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14.9M Sell
191,201
-1,595,053
-89% -$125M 8.37% 2
2025
Q2 		$140M Sell
1,786,254
-567,094
-24% -$42.3M 8.12% 2
2025
Q1 		$171M Sell
2,353,348
-438,917
-16% -$31.4M 7.82% 2
2024
Q4 		$207M Sell
2,792,265
-200,754
-7% -$14.1M 7.6% 2
2024
Q3 		$198M Buy
2,993,019
+34,597
+1% +$2.51M 6.31% 5
2024
Q2 		$273M Sell
2,958,422
-271,533
-8% -$24M 7.39% 3
2024
Q1 		$309M Sell
3,229,955
-259,960
-7% -$21.8M 7.06% 5
2023
Q4 		$266M Buy
3,489,915
+613,817
+21% +$42.7M 5.94% 5
2023
Q3 		$199M Sell
2,876,098
-776,875
-21% -$62.4M 4.99% 11
2023
Q2 		$345M Sell
3,652,973
-451,579
-11% -$39.2M 6.04% 7
2023
Q1 		$340M Sell
4,104,552
-50,831
-1% -$4M 5.97% 7
2022
Q4 		$310M Sell
4,155,383
-31,556
-0.8% -$2.43M 6.08% 8
2022
Q3 		$346M Sell
4,186,939
-309,950
-7% -$29.8M 6.69% 2
2022
Q2 		$428M Buy
4,496,889
+190,982
+4% +$19.8M 7.35% 3
2022
Q1 		$507M Buy
4,305,907
+231,667
+6% +$26M 6.69% 2
2021
Q4 		$528M Sell
4,074,240
-992,336
-20% -$116M 5.71% 7
2021
Q3 		$574M Buy
5,066,576
+160,960
+3% +$18.4M 6.5% 3
2021
Q2 		$508M Buy
4,905,616
+119,230
+2% +$11.2M 5.91% 4
2021
Q1 		$400M Buy
4,786,386
+658,447
+16% +$55.7M 5.21% 11
2020
Q4 		$377M Buy
4,127,939
+828,870
+25% +$68.8M 5.31% 8
2020
Q3 		$263M Buy
+3,299,069
New +$257M 5.47% 7

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Ownership Capital B.V.'s EW Position: Q3 2025 in Review

Ownership Capital B.V. reduced its Edwards Lifesciences (EW) stake by 89% in Q3 2025, selling an estimated $125M and leaving 191,201 shares worth $14.9M. The position accounts for 8.37% of the portfolio, ranked #2.

Ownership Capital B.V. first reported a position in EW in Q3 2020 and has held it in 21 quarters since. The position peaked at $574M in Q3 2021. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Ownership Capital B.V. held 191,201 shares of Edwards Lifesciences worth $14.9M as of Q3 2025.
  • Ownership Capital B.V. sold 1,595,053 Edwards Lifesciences shares in Q3 2025, an estimated $125M.
  • Edwards Lifesciences made up 8.37% of Ownership Capital B.V.'s portfolio in Q3 2025, its #2 holding.
  • Ownership Capital B.V. first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 21 quarters since.
  • Ownership Capital B.V.'s Edwards Lifesciences position peaked at $574M in Q3 2021.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Ownership Capital B.V.'s 13F filing for Q3 2025, filed 3 Nov 2025.